
### [MONDO:0001018](http://purl.obolibrary.org/obo/MONDO_0001018)
**Label:** lymphoblastic leukemia

**Subclasses:** [MONDO:0007243](http://purl.obolibrary.org/obo/MONDO_0007243) (Burkitts lymphoma), [MONDO:0004948](http://purl.obolibrary.org/obo/MONDO_0004948) (chronic lymphocytic leukemia), [MONDO:0020511](http://purl.obolibrary.org/obo/MONDO_0020511) (precursor b-cell acute lymphoblastic leukemia), [MONDO:0004967](http://purl.obolibrary.org/obo/MONDO_0004967) (acute lymphoblastic leukemia (disease)), 

**Corr. equiv. classes:** [Orphanet:67038](http://www.orpha.net/ORDO/Orphanet_67038), [Orphanet:99860](http://www.orpha.net/ORDO/Orphanet_99860), [Orphanet:543](http://www.orpha.net/ORDO/Orphanet_543), [OMIM:113970](http://purl.obolibrary.org/obo/OMIM_113970), [Orphanet:513](http://www.orpha.net/ORDO/Orphanet_513), 

**Class expressions from DL-Learner:**

- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) and [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) 27.37%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) and [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) 27.00%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) and (not ([HP:0000003](http://purl.obolibrary.org/obo/HP_0000003) (Multicystic kidney dysplasia))) 24.59%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) and (not ([HP:0000011](http://purl.obolibrary.org/obo/HP_0000011) (Neurogenic bladder))) 24.58%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) and (not ([HP:0000016](http://purl.obolibrary.org/obo/HP_0000016) (Urinary retention))) 24.56%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) 24.55%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) and (not ([HP:0000017](http://purl.obolibrary.org/obo/HP_0000017) (Nocturia))) 24.55%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) and (not ([HP:0000013](http://purl.obolibrary.org/obo/HP_0000013) (Hypoplasia of the uterus))) 24.55%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) and (not ([HP:0000012](http://purl.obolibrary.org/obo/HP_0000012) (Urinary urgency))) 24.55%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) and (not ([HP:0000004](http://purl.obolibrary.org/obo/HP_0000004) (null))) 24.55%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) 24.36%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) 24.33%
- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 21.95%
- Thing 21.94%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 21.94%


